2022 the Japanese Society of Medical Oncology Annual Meeting

Session information

Mini-Oral Session

[MO42] Mini-Oral Session 42 Gastrointestinal Cancer 4(Colorectal Cancer 2)
【E】

Sat. Feb 19, 2022 2:55 PM - 3:45 PM Room 12 (Prince Hall 2, B2F, The Prince Kyoto Takaragaike)

Chair:Daisuke Kotani(Department of Gastrointestinal Oncology, National Cancer Center Hospital East),Akihito Tsuji(Department of Medical oncology, Kagawa University)

Satoshi Yuki1, Yu Sunakawa2, Hiroya Taniguchi3,4, Hideaki Bando4, Kentaro Yamazaki5, Tomohiro Nishina6, Takashi Ohta7, Tadamichi Denda8, Taito Esaki9, Hisato Kawakami10, Atsuo Takashima11, Takeshi Kato12, Koji Ando13, Toshikazu Moriwaki14, Taroh Satoh15, Yoshinaga Okugawa16, Yukiko Abe17, Shogo Nomura18, Chiharu Asano19, Takayuki Yoshino4 (1.Department of Gastroenterology and Hepatology, Hokkaido University Hospital, 2.Department of Clinical Oncology, St. Marianna University School of Medicine, 3.Department of Clinical Oncology, Aichi Cancer Center Hospital, 4.Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, 5.Division of Gastrointestinal Oncology, Shizuoka Cancer Center, 6.Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center, 7.Department of Clinical Oncology, Kansai Rosai Hospital, 8.Division of Gastroenterology, Chiba Cancer Center, 9.Department of Gastrointestinal and Medical Oncology, National Kyushu Cancer Center, 10.Department of Medical Oncology, Kindai University Faculty of Medicine, 11.Division of Gastrointestinal Medical Oncology, National Cancer Center Hospital, 12.Department of Surgery, National Hospital Organization Osaka National Hospital, 13.Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 14.Department of Gastroenterology, University of Tsukuba Hospital, 15.Department of Frontier Science for Cancer and Chemotherapy, Osaka University Graduate School of Medicine, 16.Division of Genomic Medicine, Mie University Hospital, 17.G&G Science Co., Ltd., 18.Clinical Research Support Office, National Cancer Center Hospital East, 19.Institute of Health Science Innovation for Medical Care (HELIOS), Hokkaido University Hospital)

Toshiharu Hirose1, Atsuo Takashima1, Hidekazu Hirano1, Natsuko Okita1, Hirokazu Shoji1, Satoru Iwasa1, Rie Matsuo2, Kimihiko Kawamura2, Hiroya Taniguchi3, Naoto Tsuchiya4, Satoru Otsu5, Shuichi Hironaka5, Hiromichi Matsushita2, Ken Kato1 (1.Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, 2.Department of Laboratory Medicine, National Cancer Center Hospital, 3.Department of Clinical Oncology, Aichi Cancer Center Hospital, 4.Laboratory of Molecular Carcinogenesis, National Cancer Center Research Institute, 5.Department of Medical Oncology and Hematology, Oita University Faculty of Medicine)

Wen Cai1, Wenwen Bao1, Linxin Hua2, Weiting Ge2, Jianshan Mao1, Jiawei Zhang2 (1.Department of Gastroenterology (Cancer Institute, Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education), Second Affiliated Hospital of Zhejiang University School of Medicine, China, 2.Cancer Institute, Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Second Affiliated Hospital of Zhejiang University School of Medicine, China)